Barbara Gibson, MS, RN, CCRC, CIP, CHRC Regulatory Affairs Officer Vanderbilt Human Research Protection Program.

Slides:

Advertisements

Similar presentations

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.

Advertisements

Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.

Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.

Investigational Device Exemption (IDE) Overview for IRBs

Medical Device Law. FDA FDA Regulated Devices From the Beginning Hubbard Electrometer Cases Magnetic Healing Cases Original Law Required Proof of Harm.

Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,

Regulatory Pathway for Platform Technologies

Investigational Device Exemptions 21 CFR Part 812

Investigational Device Exemptions (IDE) CFR Title 21, Part 812

IRB Process & Medical Devices

1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.

Overview of FDA Device Regulations

Office of Science and Technology Center for Devices and Radiological Health, FDA William A. Herman eHealth Technologies and the FDA.

Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.

The Radioactive Drug Research Committee Approval Process for Tracer Use Anthony F. Shields, M.D., Ph.D. Karmanos Cancer Institute Wayne State University.

Carole C. Carey, BSEE, M.Engineering Director, International Staff

What is involved? What are your responsibilities? May 2013: Research Institute, Clinical Research Administration Investigational New Drug Application (IND)

Humanitarian Device Exemptions (HDE) 101 Elizabeth Hillebrenner, MSE Biomedical Engineer IDE and HDE Program Staff Center for Devices and Radiological.

510k Submission Overview Myraqa, Inc. August 22, 2012.

Single Use Expanded Access IND/IDE: FDA and IRB Requirements Before and After Use IRB Webinar October 9,2014.

Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.

Introduction to Regulation

FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.

Special Topics in IND Regulation

Medical Devices Approval Process

The FDA Landscape AdvaMed September 2008 Judith K. Meritz

+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.

Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.

Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,

Presented by: George Howe Executive Vice President Business Development & OEM Accounts.

1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.

Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)

Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)

Legal Issues Impacting Clinical Trials Medical Device Clinical Trials Update June 19, 2009.

The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.

Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.

1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.

Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.

When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.

Medical Devices IRB Determination IRB Member Continuing Education.

Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.

Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.

UNCLASSIFIED10/12/ :41 AM Slide 1 Division of Regulated Activities and Compliance.

Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.

Chapter 18 Regulations Tracking. Regulations US: FDA, almost all devices, almost all drugs European Community: devices so far, CE mark is the goal. –Active.

Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.

Investigational Devices and Humanitarian Use Devices June 2007.

REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR

Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.

BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring.

HUD and Emergent Use Walter Kraft. Device Classification Significant risk – Often involve an invasive procedure for implantation or use – Requires IDE.

Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.

AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.

1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.

PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:

November 9, 2015 February 20, 2017 Using real world evidence – industry perspective Pma indication expansion Melissa hasenbank, phd Sr. Clinical Research.

Executive Director, Registrar Corp

GCP AND MEDICAL DEVICES

Guidance for review of studies involving HCT/Ps and IND Basics

How to Put Together an IDE Application

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

Welcome New IRB Members!

Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.

Device Review Decision Tree Version Date: 4/28/15 This decision tree to be used for studies involving research on a device ( approved or unapproved)

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

FDA Resources and Meetings

Linda M. Chatwin, Esq. RAC Business Manager, UL LLC

MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA

Opening an IND: Investigator Perspective

Er. Ajai Basil Consultant, Healthcare Technologies (Medical devices)

Presentation transcript:

Barbara Gibson, MS, RN, CCRC, CIP, CHRC Regulatory Affairs Officer Vanderbilt Human Research Protection Program

Goals To facilitate understanding regarding Vanderbilt Universitys new IDE process for compliance with FDA device regulation Foster open discussion regarding the IDE process

Agenda Brief History Device defined Process Institutional policy Center for Technology Transfer and Commercialization Regulatory Process summarized Device Development Case Studies Dr. Robert Labadie Dr. Pierre DHaese Dr. Peter Konrad Questions and Discussion

Dalkon Shield Caused pelvic inflammatory disease, infertility, spontaneous septic abortion Resulted in 18 deaths and over 200,000 infections Source: Source: Source: oldnews.aadl.org Source: Source:

Medical Device Amendments of 1976 First law to give the FDA authority to review medical devices before entering the market First IRB review of medical devices Classified devices –risk based system (basis for regulatory control) Source: rx-wiki.org

Device defined Per section 201(h) of the FD&C Act, a device is "an instrument, apparatus, … contrivance, implant, in vitro reagent, or other similar or related article, including a component part, … intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, … or intended to affect the structure or any function of the body…and which does not achieve any of it's primary intended purposes through chemical action …and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes."

Examples Software, MMA, CDS IVDs Tissue engineered implants BMP Computer guided robotic surgery Nanotechnology Powered muscle stimulators Diagnostic ultrasound systems Combination products, i.e. Zecuity transdermal patch Source : Source: mobihealthnews.com Source: mag.com/news/2013/03/07/new_app_gains_ce_m ark_as_medical_device

Faculty Manual Chapter 4: Policy on Technology… …governs the ownership, protection, and transfer of Technology (Inventions, Discoveries, and other Innovations) …created or authored by University faculty members, staff members, or students. These research results include, for example, computer programs, integrated circuit designs, industrial designs, databases, technical drawings, biogenic materials, and other technical creations.

Role of CTTC Design ready IP? Market? Next steps Commercialize Further research/testing? Dont commercialize Continue research?

When is an IDE needed? All device investigations are subject to the IDE regulation (SR and NSR) Is safety and/or efficacy data being collected? Intent to support a marketing application for a new intended use/new indication for use is not a consideration for needing an IDE if SI

Relevant FDA regulations 21 CFR 50Protection of Human Subjects and Informed Consent 21 CFR 54Financial Disclosure 21 CFR 56IRB 21 CFR 812Investigational Device Exemption (IDE) – supports HDE, 510(k) or PMA 21 CFR 820Quality System Regulation Source:

Critical to start early based on needs Decision to commit Time Money Staff

Increasing Need for Support

IRBQSR Novel (Investigational device) Legally marketed off label w mods (Investigational device) FDA IDE? Legally marketed off label (Investigational use) Abbreviated IDE Requirements SR?

Regulatory Assistance Pre-Approval Determination of need for IDE from FDA Assistance with QSR resources (to be developed) Templates Pre-sub meeting guidance Liaison with FDA Assistance with submission assembly and review Assistance with IRB device documentation Post-Approval Training in Sponsor-investigator responsibilities (NSR and SR) (under development) Templates Assistance with supplement/reports assembly and review Reporting milestone reminders (to be developed) Quality assurance (to be developed)

IDE Tools and Resources

Case Studies Dr. Robert Labadie Dr. Pierre DHaese Dr. Peter Konrad

For assistance with your device research… Contact Barbara Gibson Regulatory Affairs Officer, HRPP (615)